{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:24:08Z","timestamp":1788326648891,"version":"build-2803163510"},"reference-count":166,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Silica nanoparticles (SiNPs) with antifouling properties offer a promising approach for\nenhancing ovarian cancer (OC) therapy. OC remains one of the deadliest gynecological malignancies\ndue to late-stage diagnosis, high recurrence rates, and limited treatment efficacy. Conventional\ntherapies, such as chemotherapy, often face challenges due to drug resistance and limited targeting\nability. The development of SiNPs with antifouling capabilities aims to address these issues by\nimproving drug delivery efficiency, reducing non-specific interactions, and enhancing biocompatibility.\nFunctionalizing SiNPs with cancer-specific ligands or antibodies can further improve targeting\nand uptake by ovarian cancer cells while reducing the impact on healthy tissues. Additionally,\nthe porous structure of SiNPs allows for the loading of multiple therapeutic agents, enabling combination\ntherapies that can overcome drug resistance mechanisms. In order to overcome these constraints\nand enhance MSN efficacy in cancer theranostics, this study aims to highlight technical advancements,\nincluding tumor-specific, stimuli-responsive \u201csmart\u201d MSNs and multimodal MSN-\nbased hybrid nanoplatforms. This review provides thorough knowledge about the role of mesoporous\nsilica nanoparticles for the treatment of ovarian cancer, highlighting important areas for further\nstudy as well as the difficulties associated with this area. To possibly improve therapeutic results\nby offering more accurate and targeted theranostic methods, we want to highlight the vitality\nof MSN technology as well as the significance of recent research and developments in this area.\nOverall, antifouling SiNPs represent a versatile and effective platform for ovarian cancer treatment,\nwith the potential to improve therapeutic outcomes and reduce side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0125899775385405250724152558","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:23:28Z","timestamp":1754889808000},"page":"366-384","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Next-generation Mesoporous Silica Nanoparticles: Precision-engineered Platforms for Ovarian Cancer Therapy"],"prefix":"10.2174","volume":"18","author":[{"given":"Shankar Lal","family":"Tolani","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Amity Institute of Pharmacy, Lucknow, Amity University, Sector 125, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4043-4861","authenticated-orcid":true,"given":"Shashank","family":"Soni","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Amity Institute of Pharmacy, Lucknow, Amity University, Sector 125, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1039\/c1nr10435g","volume":"3","author":"Kell A.J.","year":"2011","unstructured":"Kell A.J.; Pag\u00e9 L.; Tan S.; Charlebois I.; Boissinot M.; LeClerc M.; Simard B.; The development of a silica nanoparticle-based label-free DNA biosensor. Nanoscale  2011,3(9),3747-3754","journal-title":"Nanoscale"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/nn800072t","volume":"2","author":"Liong M.","year":"2008","unstructured":"Liong M.; Lu J.; Kovochich M.; Xia T.; Ruehm S.G.; Nel A.E.; Tamanoi F.; Zink J.I.; Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano  2008,2(5),889-896","journal-title":"ACS Nano"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1039\/C6BM00039H","volume":"4","author":"Baeza A.","year":"2016","unstructured":"Baeza A.; Manzano M.; Colilla M.; Vallet-Reg\u00ed M.; Recent advances in mesoporous silica nanoparticles for antitumor therapy: Our contribution. Biomater Sci  2016,4(5),803-813","journal-title":"Biomater Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/cm0011559","volume":"13","author":"Vallet-Regi M.","year":"2001","unstructured":"Vallet-Regi M.; R\u00e1mila A.; del Real R.P.; P\u00e9rez-Pariente J.; A new property of MCM-41: Drug delivery system. Chem Mater  2001,13(2),308-311","journal-title":"Chem Mater"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1002\/anie.200604488","volume":"46","author":"Vallet-Reg\u00ed M.","year":"2007","unstructured":"Vallet-Reg\u00ed M.; Balas F.; Arcos D.; Mesoporous materials for drug delivery. Angew Chem Int Ed  2007,46(40),7548-7558","journal-title":"Angew Chem Int Ed"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","volume":"8","author":"Nel A.E.","year":"2009","unstructured":"Nel A.E.; M\u00e4dler L.; Velegol D.; Xia T.; Hoek E.M.V.; Somasundaran P.; Klaessig F.; Castranova V.; Thompson M.; Understanding biophysicochemical interactions at the nano\u2013bio interface. Nat Mater  2009,8(7),543-557","journal-title":"Nat Mater"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1021\/ja910675v","volume":"132","author":"Walczyk D.","year":"2010","unstructured":"Walczyk D.; Bombelli F.B.; Monopoli M.P.; Lynch I.; Dawson K.A.; What the cell \u201csees\u201d in bionanoscience. J Am Chem Soc  2010,132(16),5761-5768","journal-title":"J Am Chem Soc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/ja309812z","volume":"135","author":"Lesniak A.","year":"2013","unstructured":"Lesniak A.; Salvati A.; Santos-Martinez M.J.; Radomski M.W.; Dawson K.A.; \u00c5berg C.; Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc  2013,135(4),1438-1444","journal-title":"J Am Chem Soc"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1021\/jp502624n","volume":"118","author":"Fleischer C.C.","year":"2014","unstructured":"Fleischer C.C.; Payne C.K.; Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B  2014,118,14017-14026","journal-title":"J Phys Chem B"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-443-13870-6.00010-6","author":"Mohapatra L","year":"2024","unstructured":"Mohapatra L; Tripathi AS; Mishra D; Yasir M; Maurya RK; Prajapati BG; Colorectal cancer: Understanding of disease. Colorectal Cancer : Disease and Advanced Drug Delivery Strategies  2024,1-27","journal-title":"Colorectal Cancer : Disease and Advanced Drug Delivery Strategies"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biomaterials.2015.10.019","volume":"75","author":"Mirshafiee V.","year":"2016","unstructured":"Mirshafiee V.; Kim R.; Park S.; Mahmoudi M.; Kraft M.L.; Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials  2016,75,295-304","journal-title":"Biomaterials"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.colsurfb.2014.07.013","volume":"124","author":"Jin Q.","year":"2014","unstructured":"Jin Q.; Chen Y.; Wang Y.; Ji J.; Zwitterionic drug nanocarriers: A biomimetic strategy for drug delivery. Colloids Surf B Biointerfaces  2014,124,80-86","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"20568","DOI":"10.1021\/acsami.5b04290","volume":"7","author":"Cheng X.","year":"2015","unstructured":"Cheng X.; Tian X.; Wu A.; Li J.; Tian J.; Chong Y.; Chai Z.; Zhao Y.; Chen C.; Ge C.; Protein corona influences cellular uptake of gold nanoparticles by phagocytic and nonphagocytic cells in a size-dependent manner. ACS Appl Mater Interfaces  2015,7(37),20568-20575","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1021\/nn300223w","volume":"6","author":"Lesniak A.","year":"2012","unstructured":"Lesniak A.; Fenaroli F.; Monopoli M.P.; \u00c5berg C.; Dawson K.A.; Salvati A.; Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano  2012,6(7),5845-5857","journal-title":"ACS Nano"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0290(20000405)68:1<98::AID-BIT12>3.0.CO;2-T","volume":"68","author":"Mateo C.","year":"2000","unstructured":"Mateo C.; Abian O.; Fernandez-Lafuente R.; Guisan J.M.; Reversible enzyme immobilization via a very strong and nondistorting ionic adsorption on support-polyethylenimine composites. Biotechnol Bioeng  2000,68(1),98-105","journal-title":"Biotechnol Bioeng"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"14640","DOI":"10.1073\/pnas.192581499","volume":"99","author":"Thomas M.","year":"2002","unstructured":"Thomas M.; Klibanov A.M.; Enhancing polyethylenimine\u2019s delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA  2002,99(23),14640-14645","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1023\/B:PHAM.0000016251.42392.1e","volume":"21","author":"Forrest M.L.","year":"2004","unstructured":"Forrest M.L.; Meister G.E.; Koerber J.T.; Pack D.W.; Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm Res  2004,21(2),365-371","journal-title":"Pharm Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"15282","DOI":"10.1021\/la2038558","volume":"27","author":"Dong Z.","year":"2011","unstructured":"Dong Z.; Mao J.; Yang M.; Wang D.; Bo S.; Ji X.; Phase behavior of poly(sulfobetaine methacrylate)-grafted silica nanoparticles and their stability in protein solutions. Langmuir  2011,27(24),15282-15291","journal-title":"Langmuir"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"23812","DOI":"10.1002\/jbt.23812","volume":"38","author":"Mishra D.","year":"2024","unstructured":"Mishra D.; Mohapatra L.; Tripathi A.S.; Paswan S.K.; The influential responsibility of sirtuins in senescence and associated diseases: A review. J Biochem Mol Toxicol  2024,38(9),23812","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.colsurfb.2014.12.036","volume":"126","author":"Hu F.","year":"2015","unstructured":"Hu F.; Chen K.; Xu H.; Gu H.; Functional short-chain zwitterion coated silica nanoparticles with antifouling property in protein solutions. Colloids Surf B Biointerfaces  2015,126,251-256","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2217\/nnm.15.153","volume":"10","author":"Huang Y.H.","year":"2015","unstructured":"Huang Y.H.; Zugates G.T.; Peng W.; Holtz D.; Dunton C.; Green J.J.; Hossain N.; Chernick M.R.; Padera R.F.; Langer R.; Anderson D.G.; Sawicki J.A.; Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor. Nanomedicine  2015,10,3199-3202","journal-title":"Nanomedicine"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.2217\/nnm.15.153","volume":"10","author":"Jain K.K.","year":"2015","unstructured":"Jain K.K.; Future of nanomedicine: impact on healthcare and society. Nanomedicine  2015,10(21),3199-3202","journal-title":"Nanomedicine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jpm7040012","volume":"7","author":"Fornaguera C.","year":"2017","unstructured":"Fornaguera C.; Garc\u00eda-Celma M.; Personalized nanomedicine: A revolution at the nanoscale. J Pers Med  2017,7(4),12","journal-title":"J Pers Med"},{"key":"ref=24","first-page":"803","volume":"5","author":"Pautler M.","year":"2010","unstructured":"Pautler M.; Brenner S.; Nanomedicine: Promises and challenges for the future of public health. Int J Nanomedicine  2010,5,803-809","journal-title":"Int J Nanomedicine"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"484003","DOI":"10.1088\/0953-8984\/25\/48\/484003","volume":"25","author":"Baeza A.","year":"2013","unstructured":"Baeza A.; Arcos D.; Vallet-Reg\u00ed M.; Thermoseeds for interstitial magnetic hyperthermia: From bioceramics to nanoparticles. J Phys Condens Matter  2013,25(48),484003","journal-title":"J Phys Condens Matter"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.addr.2015.09.009","volume":"95","author":"Mekaru H.","year":"2015","unstructured":"Mekaru H.; Lu J.; Tamanoi F.; Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev  2015,95,40-49","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/nano5041906","volume":"5","author":"Mart\u00ednez-Carmona M.","year":"2015","unstructured":"Mart\u00ednez-Carmona M.; Colilla M.; Vallet-Reg\u00ed M.; Smart mesoporous nanomaterials for antitumor therapy. Nanomaterials  2015,5(4),1906-1937","journal-title":"Nanomaterials"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"14901","DOI":"10.1021\/la102510c","volume":"26","author":"Ganguly A.","year":"2010","unstructured":"Ganguly A.; Ahmad T.; Ganguli A.K.; Silica mesostructures: Control of pore size and surface area using a surfactant-templated hydrothermal process. Langmuir  2010,26(18),14901-14908","journal-title":"Langmuir"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1021\/acs.chemmater.6b00877","volume":"28","author":"Bouchoucha M.","year":"2016","unstructured":"Bouchoucha M.; Cote M-F.; Gaudreault R.C.; Fortin M-A.; Kleitz F.; Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity. Chem Mater  2016,28(12),4243-4258","journal-title":"Chem Mater"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/359710a0","volume":"359","author":"Kresge C.T.","year":"1992","unstructured":"Kresge C.T.; Leonowicz M.E.; Roth W.J.; Vartuli J.C.; Beck J.S.; Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature  1992,359(6397),710-712","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0001-8686(00)00066-X","volume":"89-90","author":"\u00d8ye G.","year":"2001","unstructured":"\u00d8ye G.; Sj\u00f6blom J.; St\u00f6cker M.; Synthesis, characterization and potential applications of new materials in the mesoporous range. Adv Colloid Interface Sci  2001,89-90,439-466","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/cm9606033","volume":"9","author":"Edler K.J.","year":"1997","unstructured":"Edler K.J.; White J.W.; Further improvements in the long-range order of MCM-41 materials. Chem Mater  1997,9(5),1226-1233","journal-title":"Chem Mater"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1021\/jp983100o","volume":"103","author":"Chen L.","year":"1999","unstructured":"Chen L.; Horiuchi T.; Mori T.; Maeda K.; Postsynthesis hydrothermal restructuring of M41S mesoporous molecular sieves in water. J Phys Chem B  1999,103(8),1216-1222","journal-title":"J Phys Chem B"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1021\/ja974025i","volume":"120","author":"Zhao D.","year":"1998","unstructured":"Zhao D.; Huo Q.; Feng J.; Chmelka B.F.; Stucky G.D.; Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc  1998,120(24),6024-6036","journal-title":"J Am Chem Soc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/378366a0","volume":"378","author":"Attard G.S.","year":"1995","unstructured":"Attard G.S.; Glyde J.C.; G\u00f6ltner C.G.; Liquid-crystalline phases as templates for the synthesis of mesoporous silica. Nature  1995,378(6555),366-368","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.1021\/acs.langmuir.5b01637","volume":"31","author":"Yi Z.","year":"2015","unstructured":"Yi Z.; Dum\u00e9e L.F.; Garvey C.J.; Feng C.; She F.; Rookes J.E.; Mudie S.; Cahill D.M.; Kong L.; A new insight into growth mechanism and kinetics of mesoporous silica nanoparticles by in situ small angle X-ray scattering. Langmuir  2015,31(30),8478-8487","journal-title":"Langmuir"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1021\/cm901335k","volume":"21","author":"Qiao Z.A.","year":"2009","unstructured":"Qiao Z.A.; Zhang L.; Guo M.; Liu Y.; Huo Q.; Synthesis of mesoporous silica nanoparticles via controlled hydrolysis and condensation of silicon alkoxide. Chem Mater  2009,21(16),3823-3829","journal-title":"Chem Mater"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"13158","DOI":"10.1021\/jp201017e","volume":"115","author":"Chiang Y.D.","year":"2011","unstructured":"Chiang Y.D.; Lian H.Y.; Leo S.Y.; Wang S.G.; Yamauchi Y.; Wu K.C.W.; Controlling particle size and structural properties of mesoporous silica nanoparticles using the Taguchi method. J Phys Chem C  2011,115(27),13158-13165","journal-title":"J Phys Chem C"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1021\/ja00053a020","volume":"114","author":"Beck J.S.","year":"1992","unstructured":"Beck J.S.; Vartuli J.C.; Roth W.J.; Leonowicz M.E.; Kresge C.T.; Schmitt K.D.; Chu C.T.W.; Olson D.H.; Sheppard E.W.; McCullen S.B.; Higgins J.B.; Schlenker J.L.; A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc  1992,114(27),10834-10843","journal-title":"J Am Chem Soc"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/adma.201404059","volume":"27","author":"Shao Q.","year":"2015","unstructured":"Shao Q.; Jiang S.; Molecular understanding and design of zwitterionic materials. Adv Mater  2015,27(1),15-26","journal-title":"Adv Mater"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.reactfunctpolym.2017.07.006","volume":"118","author":"Zheng L.","year":"2017","unstructured":"Zheng L.; Sundaram H.S.; Wei Z.; Li C.; Yuan Z.; Applications of zwitterionic polymers. React Funct Polym  2017,118,51-61","journal-title":"React Funct Polym"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.actbio.2016.02.027","volume":"40","author":"Izquierdo-Barba I.","year":"2016","unstructured":"Izquierdo-Barba I.; Colilla M.; Vallet-Reg\u00ed M.; Zwitterionic ceramics for biomedical applications. Acta Biomater  2016,40,201-211","journal-title":"Acta Biomater"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/polym6051544","volume":"6","author":"Laschewsky A.","year":"2014","unstructured":"Laschewsky A.; Structures and synthesis of zwitterionic polymers. Polymer  2014,6(5),1544-1601","journal-title":"Polymer"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40824-016-0064-4","volume":"20","author":"Damodaran V.B.","year":"2016","unstructured":"Damodaran V.B.; Murthy N.S.; Bio-inspired strategies for designing antifouling biomaterials. Biomater Res  2016,20(1),18","journal-title":"Biomater Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"10799","DOI":"10.1021\/jp057266i","volume":"110","author":"Zhang Z.","year":"2006","unstructured":"Zhang Z.; Chen S.; Chang Y.; Jiang S.; Surface grafted sulfobetaine polymers via atom transfer radical polymerization as superlow fouling coatings. J Phys Chem B  2006,110(22),10799-10804","journal-title":"J Phys Chem B"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1021\/la062175d","volume":"22","author":"Zhang Z.","year":"2006","unstructured":"Zhang Z.; Chao T.; Chen S.; Jiang S.; Superlow fouling sulfobetaine and carboxybetaine polymers on glass slides. Langmuir  2006,22(24),10072-10077","journal-title":"Langmuir"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.biomaterials.2010.09.067","volume":"32","author":"Carr L.R.","year":"2011","unstructured":"Carr L.R.; Xue H.; Jiang S.; Functionalizable and nonfouling zwitterionic carboxybetaine hydrogels with a carboxybetaine dimethacrylate crosslinker. Biomaterials  2011,32(4),961-968","journal-title":"Biomaterials"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1021\/la801487f","volume":"24","author":"Yang W.","year":"2008","unstructured":"Yang W.; Cheng G.; Jiang S.; Film thickness dependence of protein adsorption from blood serum and plasma onto poly (sulfobetaine) and poly (carboxybetaine)-grafted surfaces. Langmuir  2008,24(17),9211-9216","journal-title":"Langmuir"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1016\/j.biomaterials.2009.05.058","volume":"30","author":"Cheng G.","year":"2009","unstructured":"Cheng G.; Li G.; Xue H.; Chen S.; Bryers J.D.; Jiang S.; Zwitterionic carboxybetaine polymer surfaces and their resistance to long-term biofilm formation. Biomaterials  2009,30(28),5234-5240","journal-title":"Biomaterials"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1016\/j.actbio.2014.02.046","volume":"10","author":"Liu Q.","year":"2014","unstructured":"Liu Q.; Li W.; Singh A.; Cheng G.; Liu L.; Two amino acid-based superlow fouling polymers: Poly(lysine methacrylamide) and poly(ornithine methacrylamide). Acta Biomater  2014,10(7),2956-2964","journal-title":"Acta Biomater"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.polymdegradstab.2017.03.015","volume":"139","author":"Zheng L.","year":"2017","unstructured":"Zheng L.; Sun Z.; Li C.; Wei Z.; Jain P.; Wu K.; Progress in biodegradable zwitterionic materials. Polym Degrad Stabil  2017,139,1-19","journal-title":"Polym Degrad Stabil"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/pi.4907","volume":"64","author":"Wang F.","year":"2015","unstructured":"Wang F.; Yang J.; Zhao J.; Understanding anti\u2010polyelectrolyte behavior of a well\u2010defined polyzwitterion at the single\u2010chain level. Polym Int  2015,64(8),999-1005","journal-title":"Polym Int"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1021\/jp5027114","volume":"118","author":"Shao Q.","year":"2014","unstructured":"Shao Q.; Jiang S.; Influence of charged groups on the properties of zwitterionic moieties: A molecular simulation study. J Phys Chem B  2014,118(27),7630-7637","journal-title":"J Phys Chem B"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.memsci.2017.11.057","volume":"548","author":"Ji Y.L.","year":"2018","unstructured":"Ji Y.L.; An Q.F.; Weng X.D.; Hung W.S.; Lee K.R.; Gao C.J.; Microstructure and performance of zwitterionic polymeric nanoparticle\/polyamide thin-film nanocomposite membranes for salts\/organics separation. J Membr Sci  2018,548,559-571","journal-title":"J Membr Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.memsci.2017.11.013","volume":"548","author":"Wang C.","year":"2018","unstructured":"Wang C.; Li Z.; Chen J.; Zhong Y.; Yin Y.; Cao L.; Wu H.; Zwitterionic functionalized \u201ccage-like\u201d porous organic frameworks for nanofiltration membrane with high efficiency water transport channels and anti-fouling property. J Membr Sci  2018,548,194-202","journal-title":"J Membr Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.actbio.2017.10.034","volume":"65","author":"Ou H.","year":"2018","unstructured":"Ou H.; Cheng T.; Zhang Y.; Liu J.; Ding Y.; Zhen J.; Shen W.; Xu Y.; Yang W.; Niu P.; Liu J.; An Y.; Liu Y.; Shi L.; Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells. Acta Biomater  2018,65,339-348","journal-title":"Acta Biomater"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.actbio.2015.11.038","volume":"40","author":"Huang P.","year":"2016","unstructured":"Huang P.; Liu J.; Wang W.; Zhang Y.; Zhao F.; Kong D.; Liu J.; Dong A.; Zwitterionic nanoparticles constructed from bioreducible RAFT\u2013ROP double head agent for shell shedding triggered intracellular drug delivery. Acta Biomater  2016,40,263-272","journal-title":"Acta Biomater"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.actbio.2017.10.016","volume":"64","author":"Sun H.","year":"2017","unstructured":"Sun H.; Chang M.Y.Z.; Cheng W.I.; Wang Q.; Commisso A.; Capeling M.; Wu Y.; Cheng C.; Biodegradable zwitterionic sulfobetaine polymer and its conjugate with paclitaxel for sustained drug delivery. Acta Biomater  2017,64,290-300","journal-title":"Acta Biomater"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jcis.2017.09.071","volume":"510","author":"Xie Y.","year":"2018","unstructured":"Xie Y.; Chen L.; Zhang X.; Chen S.; Zhang M.; Zhao W.; Sun S.; Zhao C.; Integrating zwitterionic polymer and Ag nanoparticles on polymeric membrane surface to prepare antifouling and bactericidal surface via Schiff-based layer-by-layer assembly. J Colloid Interface Sci  2018,510,308-317","journal-title":"J Colloid Interface Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cej.2016.04.087","volume":"300","author":"Xu X.","year":"2016","unstructured":"Xu X.; L\u00fc S.; Gao C.; Feng C.; Wu C.; Bai X.; Gao N.; Wang Z.; Liu M.; Self-fluorescent and stimuli-responsive mesoporous silica nanoparticles using a double-role curcumin gatekeeper for drug delivery. Chem Eng J  2016,300,185-192","journal-title":"Chem Eng J"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jcis.2016.09.012","volume":"485","author":"Wu J.","year":"2017","unstructured":"Wu J.; Lin Y.; Li H.; Jin Q.; Ji J.; Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy. J Colloid Interface Sci  2017,485,251-259","journal-title":"J Colloid Interface Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcis.2015.04.013","volume":"452","author":"Guo S.","year":"2015","unstructured":"Guo S.; Ja\u0144czewski D.; Zhu X.; Quintana R.; He T.; Neoh K.G.; Surface charge control for zwitterionic polymer brushes: Tailoring surface properties to antifouling applications. J Colloid Interface Sci  2015,452,43-53","journal-title":"J Colloid Interface Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.actbio.2011.03.005","volume":"7","author":"Izquierdo-Barba I.","year":"2011","unstructured":"Izquierdo-Barba I.; S\u00e1nchez-Salcedo S.; Colilla M.; Feito M.J.; Ram\u00edrez-Santill\u00e1n C.; Portol\u00e9s M.T.; Vallet-Reg\u00ed M.; Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomater  2011,7(7),2977-2985","journal-title":"Acta Biomater"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"12704","DOI":"10.1021\/la702008j","volume":"23","author":"Schepelina O.","year":"2007","unstructured":"Schepelina O.; Zharov I.; PNIPAAM-modified nanoporous colloidal films with positive and negative temperature gating. Langmuir  2007,23(25),12704-12709","journal-title":"Langmuir"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1039\/b618834f","volume":"17","author":"Zhou Z.","year":"2007","unstructured":"Zhou Z.; Zhu S.; Zhang D.; Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. J Mater Chem  2007,17(23),2428-2433","journal-title":"J Mater Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/la062219i","volume":"23","author":"Tu H.","year":"2007","unstructured":"Tu H.; Hong L.; Anthony S.M.; Braun P.V.; Granick S.; Brush-sheathed particles diffusing at brush-coated surfaces in the thermally responsive PNIPAAm system. Langmuir  2007,23(5),2322-2325","journal-title":"Langmuir"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1016\/j.biomaterials.2014.05.020","volume":"35","author":"Shahbazi M.A.","year":"2014","unstructured":"Shahbazi M.A.; Almeida P.V.; M\u00e4kil\u00e4 E.M.; Kaasalainen M.H.; Salonen J.J.; Hirvonen J.T.; Santos H.A.; Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering. Biomaterials  2014,35(26),7488-7500","journal-title":"Biomaterials"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"53653","DOI":"10.1039\/C5RA05571G","volume":"5","author":"Zhu J.","year":"2015","unstructured":"Zhu J.; Zhao X.; He C.; Zwitterionic SiO  nanoparticles as novel additives to improve the antifouling properties of PVDF membranes. RSC Advances  2015,5(66),53653-53659","journal-title":"RSC Advances"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/macp.201300552","volume":"215","author":"Dong Z.","year":"2014","unstructured":"Dong Z.; Mao J.; Wang D.; Yang M.; Wang W.; Bo S.; Ji X.; Tunable dual-thermoresponsive phase behavior of zwitterionic polysulfobetaine copolymers containing poly (N,N-dimethylaminoethyl methacrylate)-grafted silica nanoparticles in aqueous solution. Macromol Chem Phys  2014,215(1),111-120","journal-title":"Macromol Chem Phys"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bej.2018.01.013","volume":"132","author":"Zhang L.","year":"2018","unstructured":"Zhang L.; Sun Y.; Poly(carboxybetaine methacrylate)-grafted silica nanoparticle: A novel carrier for enzyme immobilization. Biochem Eng J  2018,132,122-129","journal-title":"Biochem Eng J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.aca.2013.11.049","volume":"809","author":"Huang G.","year":"2014","unstructured":"Huang G.; Xiong Z.; Qin H.; Zhu J.; Sun Z.; Zhang Y.; Peng X.; ou J.; Zou H.; Synthesis of zwitterionic polymer brushes hybrid silica nanoparticles via controlled polymerization for highly efficient enrichment of glycopeptides. Anal Chim Acta  2014,809,61-68","journal-title":"Anal Chim Acta"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1016\/j.biomaterials.2013.06.001","volume":"34","author":"Teng I.T.","year":"2013","unstructured":"Teng I.T.; Chang Y.J.; Wang L.S.; Lu H.Y.; Wu L.C.; Yang C.M.; Chiu C.C.; Yang C.H.; Hsu S.L.; Ho J.A.; Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. Biomaterials  2013,34(30),7462-7470","journal-title":"Biomaterials"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/marc.201100876","volume":"33","author":"Sun J.T.","year":"2012","unstructured":"Sun J.T.; Yu Z.Q.; Hong C.Y.; Pan C.Y.; Biocompatible zwitterionic sulfobetaine copolymer-coated mesoporous silica nanoparticles for temperature-responsive drug release. Macromol Rapid Commun  2012,33(9),811-818","journal-title":"Macromol Rapid Commun"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/marc.201400161","volume":"35","author":"Chen C.Y.","year":"2014","unstructured":"Chen C.Y.; Wang H.L.; Dual thermo- and pH-responsive zwitterionic sulfobataine copolymers for oral delivery system. Macromol Rapid Commun  2014,35(17),1534-1540","journal-title":"Macromol Rapid Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.actbio.2016.04.011","volume":"40","author":"Khatoon S.","year":"2016","unstructured":"Khatoon S.; Han H.S.; Lee M.; Lee H.; Jung D.W.; Thambi T.; Ikram M.; Kang Y.M.; Yi G.R.; Park J.H.; Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy. Acta Biomater  2016,40,282-292","journal-title":"Acta Biomater"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cej.2017.12.116","volume":"340","author":"S\u00e1nchez-Salcedo S.","year":"2018","unstructured":"S\u00e1nchez-Salcedo S.; Vallet-Reg\u00ed M.; Shahin S.A.; Glackin C.A.; Zink J.I.; Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy. Chem Eng J  2018,340,114-124","journal-title":"Chem Eng J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/bios14120575","volume":"14","author":"Zhou J.","year":"2024","unstructured":"Zhou J.; Liu C.; Zhong Y.; Luo Z.; Wu L.; A review of current developments in functionalized mesoporous silica nanoparticles: From synthesis to biosensing applications. Biosensors  2024,14(12),575","journal-title":"Biosensors"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"598722","DOI":"10.3389\/fchem.2020.598722","volume":"8","author":"Gao Y.","year":"2020","unstructured":"Gao Y.; Gao D.; Shen J.; Wang Q.; A review of mesoporous silica nanoparticle delivery systems in chemo-based combination cancer therapies. Front Chem  2020,8,598722","journal-title":"Front Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"Xu B.","year":"2023","unstructured":"Xu B.; Li S.; Shi R.; Liu H.; Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther  2023,8(1),435","journal-title":"Signal Transduct Target Ther"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acsnano.9b04266","volume":"13","author":"Grodzinski P.","year":"2019","unstructured":"Grodzinski P.; Kircher M.; Goldberg M.; Gabizon A.; Integrating nanotechnology into cancer care. ACS Nano  2019,13(7),7370-7376","journal-title":"ACS Nano"},{"key":"ref=81","first-page":"1","author":"Mohapatra L","year":"2024","unstructured":"Mohapatra L; Mishra D; Tripathi AS; Parida SK; Cancer vaccines: Types, mechanisms, and recent developments. Cancer Vaccination and Challenges  2024,1-30","journal-title":"Cancer Vaccination and Challenges"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1038\/s41467-018-06730-z","volume":"9","author":"Dogra P.","year":"2018","unstructured":"Dogra P.; Adolphi N.L.; Wang Z.; Lin Y.S.; Butler K.S.; Durfee P.N.; Croissant J.G.; Noureddine A.; Coker E.N.; Bearer E.L.; Cristini V.; Brinker C.J.; Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics. Nat Commun  2018,9(1),4551","journal-title":"Nat Commun"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","volume":"9","author":"Etheridge M.L.","year":"2013","unstructured":"Etheridge M.L.; Campbell S.A.; Erdman A.G.; Haynes C.L.; Wolf S.M.; McCullough J.; The big picture on nanomedicine: The state of investigational and approved nanomedicine products. Nanomedicine  2013,9(1),1-14","journal-title":"Nanomedicine"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1038\/s41598-017-03834-2","volume":"7","author":"Zhao Y.","year":"2017","unstructured":"Zhao Y.; Wang Y.; Ran F.; Cui Y.; Liu C.; Zhao Q.; Gao Y.; Wang D.; Wang S.; A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep  2017,7(1),4131","journal-title":"Sci Rep"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/nnm.13.191","volume":"9","author":"Toy R.","year":"2014","unstructured":"Toy R.; Peiris P.M.; Ghaghada K.B.; Karathanasis E.; Shaping cancer nanomedicine: The effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine  2014,9(1),121-134","journal-title":"Nanomedicine"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1039\/C7PY01603D","volume":"9","author":"Zhao J.","year":"2018","unstructured":"Zhao J.; Stenzel M.H.; Entry of nanoparticles into cells: The importance of nanoparticle properties. Polym Chem  2018,9(3),259-272","journal-title":"Polym Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46","author":"Behzadi S.","year":"2017","unstructured":"Behzadi S.; Serpooshan V.; Tao W.; Hamaly M.A.; Alkawareek M.Y.; Dreaden E.C.; Brown D.; Alkilany A.M.; Farokhzad O.C.; Mahmoudi M.; Cellular uptake of nanoparticles: Journey inside the cell. Chem Soc Rev  2017,46(14),4218-4244","journal-title":"Chem Soc Rev"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00204-015-1458-0","volume":"89","author":"Ge C.","year":"2015","unstructured":"Ge C.; Tian J.; Zhao Y.; Chen C.; Zhou R.; Chai Z.; Towards understanding of nanoparticle\u2013protein corona. Arch Toxicol  2015,89(4),519-539","journal-title":"Arch Toxicol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"Jokerst J.V.","year":"2011","unstructured":"Jokerst J.V.; Lobovkina T.; Zare R.N.; Gambhir S.S.; Nanoparticle PEGylation for imaging and therapy. Nanomedicine  2011,6(4),715-728","journal-title":"Nanomedicine"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"29134","DOI":"10.1039\/C4RA03277B","volume":"4","author":"Clemments A.M.","year":"2014","unstructured":"Clemments A.M.; Muniesa C.; Landry C.C.; Botella P.; Effect of surface properties in protein corona development on mesoporous silica nanoparticles. RSC Advances  2014,4(55),29134-29138","journal-title":"RSC Advances"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1039\/c3tb20139b","volume":"1","author":"Yildirim A.","year":"2013","unstructured":"Yildirim A.; Ozgur E.; Bayindir M.; Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J Mater Chem B Mater Biol Med  2013,1(14),1909-1920","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1016\/j.polymer.2010.08.022","volume":"51","author":"Chen S.","year":"2010","unstructured":"Chen S.; Li L.; Zhao C.; Zheng J.; Surface hydration: Principles and applications toward low-fouling\/nonfouling biomaterials. Polymer  2010,51(23),5283-5293","journal-title":"Polymer"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.actbio.2018.12.012","volume":"84","author":"Encinas N.","year":"2019","unstructured":"Encinas N.; Angulo M.; Astorga C.; Colilla M.; Izquierdo-Barba I.; Vallet-Reg\u00ed M.; Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties. Acta Biomater  2019,84,317-327","journal-title":"Acta Biomater"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fbioe.2020.00184","volume":"8","author":"Tao Y.","year":"2020","unstructured":"Tao Y.; Wang J.; Xu X.; Emerging and innovative theranostic approaches for mesoporous silica nanoparticles in hepatocellular carcinoma: Current status and advances. Front Bioeng Biotechnol  2020,8,184","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1021\/la201940r","volume":"27","author":"Rosen J.E.","year":"2011","unstructured":"Rosen J.E.; Gu F.X.; Surface functionalization of silica nanoparticles with cysteine: A low-fouling zwitterionic surface. Langmuir  2011,27(17),10507-10513","journal-title":"Langmuir"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1002\/anie.201712996","volume":"57","author":"Xuan M.","year":"2018","unstructured":"Xuan M.; Shao J.; Zhao J.; Li Q.; Dai L.; Li J.; Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: Applications in cancer therapy. Angew Chem Int Ed  2018,57(21),6049-6053","journal-title":"Angew Chem Int Ed"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.1038\/s41598-019-51029-8","volume":"9","author":"Cai D.","year":"2019","unstructured":"Cai D.; Liu L.; Han C.; Ma X.; Qian J.; Zhou J.; Zhu W.; Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo\/Magnetocaloric therapy on MDA-MB-231 cells. Sci Rep  2019,9(1),14475","journal-title":"Sci Rep"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"40288","DOI":"10.1039\/C8RA07574C","volume":"8","author":"Yue J.","year":"2018","unstructured":"Yue J.; Wang Z.; Shao D.; Chang Z.; Hu R.; Li L.; Luo S.; Dong W.; Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer. RSC Advances  2018,8(70),40288-40297","journal-title":"RSC Advances"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.2147\/IJN.S202910","volume":"14","author":"Yang J.","year":"2019","unstructured":"Yang J.; Teng Y.; Fu Y.; Zhang C.; Chlorins e6 loaded silica nanoparticles coated with gastric cancer cell membrane for tumor specific photodynamic therapy of gastric cancer. Int J Nanomedicine  2019,14,5061-5071","journal-title":"Int J Nanomedicine"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.1039\/C5NR04119H","volume":"8","author":"van Rijt S.H.","year":"2016","unstructured":"van Rijt S.H.; B\u00f6l\u00fckbas D.A.; Argyo C.; Wipplinger K.; Naureen M.; Datz S.; Eickelberg O.; Meiners S.; Bein T.; Schmid O.; Stoeger T.; Applicability of avidin protein coated mesoporous silica nanoparticles as drug carriers in the lung. Nanoscale  2016,8(15),8058-8069","journal-title":"Nanoscale"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/jbm.a.35049","volume":"102","author":"Luo Z.","year":"2014","unstructured":"Luo Z.; Hu Y.; Xin R.; Zhang B.; Li J.; Ding X.; Hou Y.; Yang L.; Cai K.; Surface functionalized mesoporous silica nanoparticles with natural proteins for reduced immunotoxicity. J Biomed Mater Res A  2014,102(11),3781-3794","journal-title":"J Biomed Mater Res A"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.xphs.2017.06.019","volume":"106","author":"Natfji A.A.","year":"2017","unstructured":"Natfji A.A.; Ravishankar D.; Osborn H.M.I.; Greco F.; Parameters affecting the enhanced permeability and retention effect: The need for patient selection. J Pharm Sci  2017,106(11),3179-3187","journal-title":"J Pharm Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3762\/bjnano.10.16","volume":"10","author":"Villaverde G.","year":"2019","unstructured":"Villaverde G.; Baeza A.; Targeting strategies for improving the efficacy of nanomedicine in oncology. Beilstein J Nanotechnol  2019,10,168-181","journal-title":"Beilstein J Nanotechnol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1021\/acsami.9b21214","volume":"12","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Xie Y.; Kilchrist K.V.; Li J.; Duvall C.L.; Oupick\u00fd D.; Endosomolytic and tumor-penetrating mesoporous silica nanoparticles for siRNA\/miRNA combination cancer therapy. ACS Appl Mater Interfaces  2020,12(4),4308-4322","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1172\/JCI92284","volume":"127","author":"Liu X.","year":"2017","unstructured":"Liu X.; Lin P.; Perrett I.; Lin J.; Liao Y.P.; Chang C.H.; Jiang J.; Wu N.; Donahue T.; Wainberg Z.; Nel A.E.; Meng H.; Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer. J Clin Invest  2017,127(5),2007-2018","journal-title":"J Clin Invest"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1800025","DOI":"10.1002\/adfm.201800025","volume":"28","author":"Kuang J.","year":"2018","unstructured":"Kuang J.; Song W.; Yin J.; Zeng X.; Han S.; Zhao Y.P.; Tao J.; Liu C-J.; He X-H.; Zhang X-Z.; iRGD modified chemo-immunotherapeutic nanoparticles for enhanced immunotherapy against glioblastoma. Adv Funct Mater  2018,28(17),1800025","journal-title":"Adv Funct Mater"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1039\/C7ME00050B","volume":"2","author":"Liu X.","year":"2017","unstructured":"Liu X.; Jiang J.; Ji Y.; Lu J.; Chan R.; Meng H.; Targeted drug delivery using iRGD peptide for solid cancer treatment. Mol Syst Des Eng  2017,2(4),370-379","journal-title":"Mol Syst Des Eng"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","volume":"110-111","author":"Ruoslahti E.","year":"2017","unstructured":"Ruoslahti E.; Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev  2017,110-111,3-12","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1016\/j.biomaterials.2014.01.082","volume":"35","author":"Kang T.","year":"2014","unstructured":"Kang T.; Gao X.; Hu Q.; Jiang D.; Feng X.; Zhang X.; Song Q.; Yao L.; Huang M.; Jiang X.; Pang Z.; Chen H.; Chen J.; iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Biomaterials  2014,35(14),4319-4332","journal-title":"Biomaterials"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1470-2045(03)01194-X","volume":"4","author":"Pawelek J.M.","year":"2003","unstructured":"Pawelek J.M.; Low K.B.; Bermudes D.; Bacteria as tumour-targeting vectors. Lancet Oncol  2003,4(9),548-556","journal-title":"Lancet Oncol"},{"key":"ref=111","first-page":"6","volume":"2","author":"Li Z.","year":"2015","unstructured":"Li Z.; Fan D.; Xiong D.; Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Stem Cell Investig  2015,2,6","journal-title":"Stem Cell Investig"},{"key":"ref=112","first-page":"1","volume":"4","author":"Vallet-Reg\u00ed M.","year":"2018","unstructured":"Vallet-Reg\u00ed M.; Paris J.L.; Torre P.; Caba\u00f1as M.V.; Manzano M.; Flores A.I.; Mesenchymal stem cells from human placenta as nanoparticle delivery vectors. Insights Stem Cells  2018,4(1),1","journal-title":"Insights Stem Cells"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2174\/0929867323666160406120923","volume":"23","author":"Raj R.","year":"2016","unstructured":"Raj R.; Das S.; Prospects of bacteriotherapy with nanotechnology in nanoparticle-drug conjugation approach for cancer therapy. Curr Med Chem  2016,23(14),1477-1494","journal-title":"Curr Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1801309","DOI":"10.1002\/advs.201801309","volume":"6","author":"Suh S.","year":"2019","unstructured":"Suh S.; Jo A.; Traore M.A.; Zhan Y.; Coutermarsh-Ott S.L.; Ringel-Scaia V.M.; Allen I.C.; Davis R.M.; Behkam B.; Nanoscale bacteria\u2010enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine. Adv Sci  2019,6(3),1801309","journal-title":"Adv Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1901942","DOI":"10.1002\/admi.201901942","volume":"7","author":"Moreno V.M.","year":"2020","unstructured":"Moreno V.M.; \u00c1lvarez E.; Izquierdo-Barba I.; Baeza A.; Serrano-L\u00f3pez J.; Vallet-Reg\u00ed M.; Bacteria as nanoparticles carrier for enhancing penetration in a tumoral matrix model. Adv Mater Interfaces  2020,7(11),1901942","journal-title":"Adv Mater Interfaces"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2174\/092986712800784667","volume":"19","author":"Cardoso M.M.","year":"2012","unstructured":"Cardoso M.M.; Pe\u00e7a I.N.; Roque A.C.A.; Antibody-conjugated nanoparticles for therapeutic applications. Curr Med Chem  2012,19(19),3103-3127","journal-title":"Curr Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1166\/jbn.2016.2318","volume":"12","author":"Dr\u00e9au D.","year":"2016","unstructured":"Dr\u00e9au D.; Moore L.J.; Alvarez-Berrios M.P.; Tarannum M.; Mukherjee P.; Vivero-Escoto J.L.; Mucin-1-antibody-conjugated mesoporous silica nanoparticles for selective breast cancer detection in a mucin-1 transgenic murine mouse model. J Biomed Nanotechnol  2016,12(12),2172-2184","journal-title":"J Biomed Nanotechnol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41598-017-18932-4","volume":"8","author":"Mandal T.","year":"2018","unstructured":"Mandal T.; Beck M.; Kirsten N.; Lind\u00e9n M.; Buske C.; Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles. Sci Rep  2018,8(1),989","journal-title":"Sci Rep"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-017-0492-6","volume":"36","author":"Zhou S.","year":"2017","unstructured":"Zhou S.; Wu D.; Yin X.; Jin X.; Zhang X.; Zheng S.; Wang C.; Liu Y.; Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells. J Exp Clin Cancer Res  2017,36(1),24","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.2147\/IJN.S164393","volume":"13","author":"Ngamcherdtrakul W.","year":"2018","unstructured":"Ngamcherdtrakul W.; Sangvanich T.; Reda M.; Gu S.; Bejan D.; Yantasee W.; Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery. Int J Nanomedicine  2018,13,4015-4027","journal-title":"Int J Nanomedicine"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/17425247.3.3.311","volume":"3","author":"Farokhzad O.C.","year":"2006","unstructured":"Farokhzad O.C.; Karp J.M.; Langer R.; Nanoparticle\u2013aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv  2006,3(3),311-324","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/sctm.17-0289","volume":"7","author":"Boesch M.","year":"2018","unstructured":"Boesch M.; Spizzo G.; Seeber A.; Aggressive colorectal cancer: Role of epithelial cell adhesion molecule in cancer stem cells and epithelial-to-mesenchymal transition. Stem Cells Transl Med  2018,7(6),495-501","journal-title":"Stem Cells Transl Med"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejps.2015.12.014","volume":"83","author":"Xie X.","year":"2016","unstructured":"Xie X.; Li F.; Zhang H.; Lu Y.; Lian S.; Lin H.; Gao Y.; Jia L.; EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Eur J Pharm Sci  2016,83,28-35","journal-title":"Eur J Pharm Sci"},{"key":"ref=124","first-page":"2495","volume":"4","author":"Pascual L.","year":"2016","unstructured":"Pascual L.; Cerqueira-Coutinho C.; Garc\u00eda-Fern\u00e1ndez A.; de Luis B.; Bernardes E.S.; Albernaz M.S.; MUC1 aptamer-capped mesoporous silica nanoparticles for controlled release in breast cancer. J Mater Chem B Mater Biol Med  2016,4,2495-2505","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"36005","DOI":"10.1039\/C9RA07974B","volume":"9","author":"Tuna B.G.","year":"2019","unstructured":"Tuna B.G.; Atalay P.B.; Kuku G.; Acar E.E.; Kara H.K.; Yilmaz M.D.; Ozalp V.C.; Enhanced antitumor activity of carbendazim on HeLa cervical cancer cells by aptamer mediated controlled release. RSC Advances  2019,9(62),36005-36010","journal-title":"RSC Advances"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/10717544.2018.1519001","volume":"25","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Huang G.; Huang H.; The glyconanoparticle as carrier for drug delivery. Drug Deliv  2018,25(1),1840-1845","journal-title":"Drug Deliv"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"181027","DOI":"10.1098\/rsos.181027","volume":"5","author":"Liu W.","year":"2018","unstructured":"Liu W.; Zhu Y.; Wang F.; Li X.; Liu X.; Pang J.; Pan W.; Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. R Soc Open Sci  2018,5(12),181027","journal-title":"R Soc Open Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.030","volume":"143","author":"Zhao R.","year":"2017","unstructured":"Zhao R.; Li T.; Zheng G.; Jiang K.; Fan L.; Shao J.; Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. Biomaterials  2017,143,1-16","journal-title":"Biomaterials"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/chem.201202038","volume":"19","author":"Chen Z.","year":"2013","unstructured":"Chen Z.; Li Z.; Lin Y.; Yin M.; Ren J.; Qu X.; Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chemistry  2013,19(5),1778-1783","journal-title":"Chemistry"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.jinorgbio.2004.07.009","volume":"98","author":"Russell-Jones G.","year":"2004","unstructured":"Russell-Jones G.; McTavish K.; McEwan J.; Rice J.; Nowotnik D.; Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. J Inorg Biochem  2004,98(10),1625-1633","journal-title":"J Inorg Biochem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"8452","DOI":"10.1039\/C4TB01263A","volume":"2","author":"Wang J.","year":"2014","unstructured":"Wang J.; Wang T.T.; Gao P.F.; Huang C.Z.; Biomolecules-conjugated nanomaterials for targeted cancer therapy. J Mater Chem B Mater Biol Med  2014,2(48),8452-8465","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=132","first-page":"449","volume":"15","author":"Jafari M.","year":"2016","unstructured":"Jafari M.; Heidari D.; Ebrahimnejad P.; Synthesizing and characterizing functionalized short multiwall carbon nanotubes with folate, magnetite and polyethylene glycol as multi-targeted nanocarrier of anti-cancer drugs. Iran J Pharm Res  2016,15(2),449-456","journal-title":"Iran J Pharm Res"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"18462","DOI":"10.1021\/acsami.7b02457","volume":"9","author":"Cheng W.","year":"2017","unstructured":"Cheng W.; Nie J.; Xu L.; Liang C.; Peng Y.; Liu G.; Wang T.; Mei L.; Huang L.; Zeng X.; pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl Mater Interfaces  2017,9(22),18462-18473","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/21691401.2018.1431651","volume":"46","author":"Li Z.","year":"2018","unstructured":"Li Z.; Zhang Y.; Zhang K.; Wu Z.; Feng N.; Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Artif Cells Nanomed Biotechnol  2018,46(sup1),578-587","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"Wilhelm S.","year":"2016","unstructured":"Wilhelm S.; Tavares A.J.; Dai Q.; Ohta S.; Audet J.; Dvorak H.F.; Chan W.C.W.; Analysis of nanoparticle delivery to tumours. Nat Rev Mater  2016,1(5),16014","journal-title":"Nat Rev Mater"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"Fan D.","year":"2023","unstructured":"Fan D.; Cao Y.; Cao M.; Wang Y.; Cao Y.; Gong T.; Nanomedicine in cancer therapy. Signal Transduct Target Ther  2023,8(1),293","journal-title":"Signal Transduct Target Ther"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/nano11030780","volume":"11","author":"Bevilacqua P.","year":"2021","unstructured":"Bevilacqua P.; Nuzzo S.; Torino E.; Condorelli G.; Salvatore M.; Grimaldi A.M.; Antifouling strategies of nanoparticles for diagnostic and therapeutic application: A systematic review of the literature. Nanomaterials  2021,11(3),780","journal-title":"Nanomaterials"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cis.2015.10.009","volume":"226","author":"Khung Y.L.","year":"2015","unstructured":"Khung Y.L.; Narducci D.; Surface modification strategies on mesoporous silica nanoparticles for anti-biofouling zwitterionic film grafting. Adv Colloid Interface Sci  2015,226(Pt B),166-186","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/pat.4505","volume":"30","author":"Beltr\u00e1n-Osuna \u00c1.A.","year":"2019","unstructured":"Beltr\u00e1n-Osuna \u00c1.A.; R\u00f3denas-Rochina J.; G\u00f3mez Ribelles J.L.; Perilla J.E.; Antifouling zwitterionic  \u2010  particles for biomedical applications. Polym Adv Technol  2019,30(3),688-697","journal-title":"Polym Adv Technol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"23125","DOI":"10.1021\/acs.langmuir.4c02664","volume":"40","author":"Moayedi S.","year":"2024","unstructured":"Moayedi S.; Xia W.; Lundergan L.; Yuan H.; Xu J.; Zwitterionic polymers for biomedical applications: Antimicrobial and antifouling strategies toward implantable medical devices and drug delivery. Langmuir  2024,40(44),23125-23145","journal-title":"Langmuir"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/pharmaceutics13071067","volume":"13","author":"Rastegari E.","year":"2021","unstructured":"Rastegari E.; Hsiao Y.J.; Lai W.Y.; Lai Y.H.; Yang T.C.; Chen S.J.; Huang P.I.; Chiou S.H.; Mou C.Y.; Chien Y.; An update on mesoporous silica nanoparticle applications in nanomedicine. Pharmaceutics  2021,13(7),1067","journal-title":"Pharmaceutics"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bioactmat.2023.02.026","volume":"26","author":"Liao J.","year":"2023","unstructured":"Liao J.; Li X.; Fan Y.; Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions. Bioact Mater  2023,26,387-412","journal-title":"Bioact Mater"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40846-015-0029-4","volume":"35","author":"Zhang H.","year":"2015","unstructured":"Zhang H.; Chiao M.; Anti-fouling coatings of poly (dimethylsiloxane) devices for biological and biomedical applications. J Med Biol Eng  2015,35(2),143-155","journal-title":"J Med Biol Eng"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"135106","DOI":"10.1063\/1.5140707","volume":"127","author":"Beltr\u00e1n-Osuna \u00c1.A.","year":"2020","unstructured":"Beltr\u00e1n-Osuna \u00c1.A.; G\u00f3mez-Ribelles J.L.; Perilla J.E.; Temperature and pH responsive behavior of antifouling zwitterionic mesoporous silica nanoparticles. J Appl Phys  2020,127(13),135106","journal-title":"J Appl Phys"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"58223","DOI":"10.1021\/acsami.0c17427","volume":"12","author":"Saha P.","year":"2020","unstructured":"Saha P.; Santi M.; Emondts M.; Roth H.; Rahimi K.; Gro\u00dfkurth J.; Ganguly R.; Wessling M.; Singha N.K.; Pich A.; Stimuli-responsive zwitterionic core\u2013shell microgels for antifouling surface coatings. ACS Appl Mater Interfaces  2020,12(52),58223-58238","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.7150\/thno.26345","volume":"8","author":"Di Lorenzo G.","year":"2018","unstructured":"Di Lorenzo G.; Ricci G.; Severini G.M.; Romano F.; Biffi S.; Imaging and therapy of ovarian cancer: Clinical application of nanoparticles and future perspectives. Theranostics  2018,8(16),4279-4294","journal-title":"Theranostics"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.memsci.2016.12.051","volume":"526","author":"D\u00edez B.","year":"2017","unstructured":"D\u00edez B.; Rold\u00e1n N.; Mart\u00edn A.; Sotto A.; Perdig\u00f3n-Mel\u00f3n J.A.; Arsuaga J.; Rosal R.; Fouling and biofouling resistance of metal-doped mesostructured silica\/polyethersulfone ultrafiltration membranes. J Membr Sci  2017,526,252-263","journal-title":"J Membr Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/jfb15030074","volume":"15","author":"Almomen A.","year":"2024","unstructured":"Almomen A.; Alhowyan A.; A comprehensive study on folate-targeted mesoporous silica nanoparticles loaded with 5-Fluorouracil for the enhanced treatment of gynecological cancers. J Funct Biomater  2024,15(3),74","journal-title":"J Funct Biomater"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bioactmat.2020.12.010","volume":"6","author":"Yang M.","year":"2021","unstructured":"Yang M.; Li J.; Gu P.; Fan X.; The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact Mater  2021,6(7),1973-1987","journal-title":"Bioact Mater"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"255","DOI":"10.34172\/bi.2023.25298","volume":"13","author":"Torabi M.","year":"2023","unstructured":"Torabi M.; Aghanejad A.; Savadi P.; Barzegari A.; Omidi Y.; Barar J.; Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells. Bioimpacts  2023,13(3),255-267","journal-title":"Bioimpacts"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.xphs.2023.01.011","volume":"112","author":"Salve R.","year":"2023","unstructured":"Salve R.; Kumar P.; Chaudhari B.P.; Gajbhiye V.; Aptamer tethered bio-responsive mesoporous silica nanoparticles for efficient targeted delivery of paclitaxel to treat ovarian cancer cells. J Pharm Sci  2023,112(5),1450-1459","journal-title":"J Pharm Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.niox.2016.02.002","volume":"54","author":"El-Sehemy A.","year":"2016","unstructured":"El-Sehemy A.; Postovit L.M.; Fu Y.; Nitric oxide signaling in human ovarian cancer: A potential therapeutic target. Nitric Oxide  2016,54,30-37","journal-title":"Nitric Oxide"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"A1345","DOI":"10.1136\/jitc-2023-SITC2023.1219","volume":"11","author":"Marwedel BR","year":"2023","unstructured":"Marwedel BR; Noureddine A; Tang L; Serda RE; 1219\u2005Lipid-coated mesoporous silica nanoparticles (MSN) accumulate selectively in tumor-burdened tissues in a mouse model of serous epithelial ovarian cancer. J Immunother Cancer  2023,11(Suppl 1),A1345-A1345","journal-title":"J Immunother Cancer"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/nano10050916","volume":"10","author":"Gisbert-Garzar\u00e1n M.","year":"2020","unstructured":"Gisbert-Garzar\u00e1n M.; Vallet-Reg\u00ed M.; Influence of the surface functionalization on the fate and performance of mesoporous silica nanoparticles. Nanomaterials  2020,10(5),916","journal-title":"Nanomaterials"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.2147\/IJN.S273064","volume":"16","author":"Castillo R.R.","year":"2021","unstructured":"Castillo R.R.; Vallet-Reg\u00ed M.; Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections. Int J Nanomedicine  2021,16,4409-4430","journal-title":"Int J Nanomedicine"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/pharmaceutics15020447","volume":"15","author":"Dumontel B.","year":"2023","unstructured":"Dumontel B.; Conejo-Rodr\u00edguez V.; Vallet-Reg\u00ed M.; Manzano M.; Natural biopolymers as smart coating materials of mesoporous silica nanoparticles for drug delivery. Pharmaceutics  2023,15(2),447","journal-title":"Pharmaceutics"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"121173","DOI":"10.1016\/j.ijpharm.2021.121173","volume":"609","author":"Kalyane D.","year":"2021","unstructured":"Kalyane D.; Kumar N.; Anup N.; Rajpoot K.; Maheshwari R.; Sengupta P.; Kalia K.; Tekade R.K.; Recent advancements and future submissions of silica core-shell nanoparticles. Int J Pharm  2021,609,121173","journal-title":"Int J Pharm"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018025589","volume":"36","author":"Navyatha B","year":"2019","unstructured":"Navyatha B; Nara S; Theranostic nanostructures for ovarian cancer. Crit Rev Ther Drug Carrier Syst  2019,36(4),305-371","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1021\/acsami.0c21620","volume":"13","author":"Ouyang Z.","year":"2021","unstructured":"Ouyang Z.; Li D.; Xiong Z.; Song C.; Gao Y.; Liu R.; Shen M.; Shi X.; Antifouling dendrimer-entrapped copper sulfide nanoparticles enable photoacoustic imaging-guided targeted combination therapy of tumors and tumor metastasis. ACS Appl Mater Interfaces  2021,13(5),6069-6080","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.memsci.2005.02.025","volume":"258","author":"Park N.","year":"2005","unstructured":"Park N.; Kwon B.; Kim I.; Cho J.; Biofouling potential of various NF membranes with respect to bacteria and their soluble microbial products (SMP): Characterizations, flux decline, and transport parameters. J Membr Sci  2005,258(1-2),43-54","journal-title":"J Membr Sci"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.memsci.2009.05.041","volume":"342","author":"Yu H.","year":"2009","unstructured":"Yu H.; Cao Y.; Kang G.; Liu J.; Li M.; Yuan Q.; Enhancing antifouling property of polysulfone ultrafiltration membrane by grafting zwitterionic copolymer via UV-initiated polymerization. J Membr Sci  2009,342(1-2),6-13","journal-title":"J Membr Sci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"18584","DOI":"10.1021\/acsami.7b04840","volume":"9","author":"Knowles B.R.","year":"2017","unstructured":"Knowles B.R.; Wagner P.; Maclaughlin S.; Higgins M.J.; Molino P.J.; Silica nanoparticles functionalized with zwitterionic sulfobetaine siloxane for application as a versatile antifouling coating system. ACS Appl Mater Interfaces  2017,9(22),18584-18594","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/bios14070326","volume":"14","author":"Mladenovi\u0107 M.","year":"2024","unstructured":"Mladenovi\u0107 M.; Jari\u0107 S.; Mund\u017ei\u0107 M.; Pavlovi\u0107 A.; Bobrinetskiy I.; Kne\u017eevi\u0107 N.\u017d.; Biosensors for cancer biomarkers based on mesoporous silica nanoparticles. Biosensors  2024,14(7),326","journal-title":"Biosensors"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1564188","DOI":"10.3389\/fnano.2025.1564188","volume":"7","author":"Fatima R.","year":"2025","unstructured":"Fatima R.; Katiyar P.; Kushwaha K.; Recent advances in mesoporous silica nanoparticle: Synthesis, drug loading, release mechanisms, and diverse applications. Front Nanotechnol  2025,7,1564188","journal-title":"Front Nanotechnol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12645-024-00250-w","volume":"15","author":"Dutta Gupta Y.","year":"2024","unstructured":"Dutta Gupta Y.; Mackeyev Y.; Krishnan S.; Bhandary S.; Mesoporous silica nanotechnology: Promising advances in augmenting cancer theranostics. Cancer Nanotechnol  2024,15(1),9","journal-title":"Cancer Nanotechnol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/pharmaceutics14081579","volume":"14","author":"Koohi Moftakhari Esfahani M.","year":"2022","unstructured":"Koohi Moftakhari Esfahani M.; Alavi S.E.; Cabot P.J.; Islam N.; Izake E.L.; Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy. Pharmaceutics  2022,14(8),1579","journal-title":"Pharmaceutics"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775385405250724152558","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244358\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775385405250724152558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:57:01Z","timestamp":1788325021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244358\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":166,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0125899775385405250724152558","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}